BioLargo, Inc.’s CEO Discusses Business Milestones and FDA Progress with Uptick Newswire’s Stock Day Podcast PHOENIX, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Dennis Calvert, CEO of BioLargo, Inc. (OTCQB:BLGO), recently spoke with Stock Day Podcast’s Everett Jolly to update listeners on the company’s recent...

BioLargo acquires breakthrough stem cell therapy technology to expand medical product portfolio WESTMINSTER, Calif., Oct. 02, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB:BLGO), developer of sustainable science and technologies and a full-service environmental engineering company, announced...

BioLargo CEO Dennis Calvert Elaborates on the Importance of its new Engineering Division and Financing to Accelerate Commercialization Phoenix, AZ, Sept. 20, 2017 (GLOBE NEWSWIRE) -- Dennis Calvert, CEO of BioLargo, Inc. (OTCQB: BLGO) was interviewed on the Uptick Network Stock Day Podcast with host Everett Jolly. In the interview...

BioLargo Achieves Important Milestones - Sales Increase by 176% Westminster, CA , Aug. 15, 2017 (GLOBE NEWSWIRE) -- BioLargo Achieves Important Milestones - Sales Increase by 176% Westminster, CA – August 15, 2017 – BioLargo, Inc., (OTCQB: BLGO;...